I kliniske forsøg reducerede robenacoxib halten og inflammation hos hunde med kronisk osteoarthritis og reducerede smerter og inflammation efter ortopædkirurgi eller bløddelskirurgi hos hunde.
In clinical trials robenacoxib reduced the lameness and inflammation of dogs with chronic osteoarthritis and reduced pain and inflammation after orthopaedic or soft tissue surgery in dogs.